Home › Research › Disparities
Access to healthcare services and adherence to treatments for people with dementia among ethnic minority groups: a scoping review
Elisa Aguzzoli, Magdalena Walbaum, Martin Richard John Knapp. Frontiers in Dementia, 2026-02-16
Topic: Risk, prevention and care in population studies
Plain-language summary
Seventeen articles were included. People with dementia from ethnic minority groups report lower quality care received. They are less likely to be prescribed and receive anti-dementia medications, and they have lower adherence rates compared to their White counterparts when these medications are prescribed. Identified barriers to access and adherence to treatments include cultural factors, religious beliefs, viewing dementia as a normal part of ageing, stigma, limited language proficiency, inadequate facilities and services not tailored to the specific needs of minority ethnic groups. This research highlights persistent inequalities among people with dementia from ethnic minority groups. More research is needed to address these issues and fully understand the factors influencing access to care services and attitudes towards medications among people with dementia. Policymakers and researchers should emphasise the importance of designing and implementing culturally tailored interventions to reduce these persistent inequalities.
What this study adds
Evidence grade: Low
This scoping review found that people with dementia from ethnic minority groups receive lower quality care, are less likely to be prescribed anti-dementia medications, and have lower adherence when prescribed. It identifies barriers to access and adherence but does not test a treatment or cure.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Aguzzoli, E., Walbaum, M., & Knapp, M. R. J. (2026). Access to healthcare services and adherence to treatments for people with dementia among ethnic minority groups: a scoping review. Frontiers in Dementia. https://doi.org/10.3389/frdem.2026.1735266
Vancouver
Aguzzoli E, Walbaum M, Knapp MRJ. Access to healthcare services and adherence to treatments for people with dementia among ethnic minority groups: a scoping review. Frontiers in Dementia. 2026. doi:10.3389/frdem.2026.1735266. PMID: 41777856.
BibTeX
@article{aguzzoli2026-41777856,
author = {Aguzzoli, Elisa and Walbaum, Magdalena and Knapp, Martin Richard John},
title = {{Access to healthcare services and adherence to treatments for people with dementia among ethnic minority groups: a scoping review}},
journal = {Frontiers in Dementia},
year = {2026},
doi = {10.3389/frdem.2026.1735266},
pmid = {41777856},
url = {https://doi.org/10.3389/frdem.2026.1735266}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- People with dementia from ethnic minority groups report lower quality care received.
- They are less likely to be prescribed and receive anti-dementia medications, and they have lower adherence rates compared to their White counterparts when these medications are prescribed.
- Identified barriers to access and adherence to treatments include cultural factors, religious beliefs, viewing dementia as a normal part of ageing, stigma, limited language proficiency, inadequate facilities and services not tailored to the specific needs of minority ethnic groups.
- This research highlights persistent inequalities among people with dementia from ethnic minority groups.
- More research is needed to address these issues and fully understand the factors influencing access to care services and attitudes towards medications among people with dementia.
Why it matters
This scoping review found that people with dementia from ethnic minority groups receive lower quality care, are less likely to be prescribed anti-dementia medications, and have lower adherence when prescribed. It identifies barriers to access and adherence but does not test a treatment or cure.
New to this subject? Start with our plain-English guide: Disparities →
Study details
- Evidence strengthLow
How this study scored 35/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Frontiers in Dementia) |
| Journal's citation record | 0 / 4 | Frontiers in Dementia: journal h-index 13 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.5 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 3 / 6 | Cited 4.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Martin Richard John Knapp: h-index 120 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | London School of Economics and Political Science: institution h-index 595 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41777856) |
| Free to read | 2 / 2 | Free to read |
| Total | 35 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3389/frdem.2026.1735266
- PubMed: 41777856
- Original source →
- Free full text: Frontiers in Dementia →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Disparities from nearby years
Also tagged “prevalence”
1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.